London medtech Sava secures $36m Series B led by CONTOUR-maker Ascensia Diabetes Care to take its multi-analyte glucose ...
Two new lawsuits allege Dexcom G7 monitors malfunctioned in children, causing diabetic ketoacidosis and hypoglycemic seizures ...
Zacks Investment Research on MSN
Beta Bionics stock down despite iLet-Eversense 365 integration deal
Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated ...
DexCom stock (ISIN US2521311074) closed at USD 86.62 on Nasdaq on September 25, 2026, down 0.97 percent from the prior close.
New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results